ライフサイエンスコーパス: blood serum

1 in the complex matrix of filtered undiluted blood serum.

2 m the biochemically complex sample matrix of blood serum.

3 AI-2 in clinical samples such as saliva and blood serum.

4 ic proteins even in complex samples, such as blood serum.

5 n of abnormal HSA concentration in a control blood serum.

6 ing and adult brain and is also found in the blood serum.

7 from high mannose glycan isomers from human blood serum.

8 ed for the selective sensing of a protein in blood serum.

9 ements demonstrated by zinc determination in blood serum.

10 ants of cell-conditioned medium or mammalian blood serum.

11 chemical tool for the clinical diagnosis of blood serum.

12 molecular-weight proteinaceous components of blood serum.

13 ar detection limit are possible in undiluted blood serum.

14 re-useable manner to the target in up to 50% blood serum.

15 blems when applied in complex fluids such as blood serum.

16 polymer (NIP) electrodes in both buffer and blood serum.

17 100 nM-100 muM in buffer and 1-100 muM human blood serum.

18 00 fmol of glycoprotein and 0.1 muL of human blood serum.

19 gical signature for SCZ can be identified in blood serum.

20 ntibodies directly in undiluted, unprocessed blood serum.

21 biological fluids such as fish extracts and blood serum.

22 teriorates rapidly when immersed directly in blood serum.

23 ion of unknown alpha-amylase activity in the blood serum.

24 llenged with complex sample matrices such as blood serum.

25 ty when the sensor is challenged directly in blood serum.

26 ke of the IF complex of vitamin B(12) to the blood serum.

27 directly in undiluted, otherwise unmodified blood serum.

28 mployment in complex sample matrices such as blood serum.

29 clinical studies of cytokines, and (3) human blood serum.

30 d in complex, multicomponent samples such as blood serum.

31 and at clinically relevant concentrations in blood serum.

32 ples and complex biological mixtures such as blood serum.

33 in and potential interfering agents found in blood serum.

34 let-derived growth factor (PDGF) directly in blood serum.

35 well as the actin depolymerizing activity of blood serum.

36 ases by 27% for the same experiment in human blood serum.

37 complex, contaminant-ridden samples such as blood serum.

38 s typically found in clinical tests of human blood serum.

39 ane proteins and proteins contained in human blood serum.

40 xel and 5 x 10(-9) M for cyclophosphamide in blood serum.

41 on; it is one of the major mitogens found in blood serum.

42 xtraction of acetaminophen (APAP) from human blood serum.

43 -linked Neu5Ac present on PSA extracted from blood serum.

44 or TDM of paclitaxel and cyclophosphamide in blood serum.

45 to real CRP concentration (119 nM) in human blood serum.

46 bility in both phosphate-buffered saline and blood serum.

47 of around 90% beyond 1pM and within 25nM in blood serum.

48 occur in the DSC profile of NSCLC patient's blood serum.

49 osidase concentrations in both PBS and human blood serum.

50 both in buffer and in heat-inactivated human blood serum.

51 bust detection of this bacterial pathogen in blood serum.

52 ed sensitivity of glucose detection in human blood serum.

53 y measure antibodies in a drop of unmodified blood serum.

54 detection of alpha-amylase activity in human blood serum.

55 ers, in artificial gastric acid, and even in blood serum.

56 cting unknown quantities of amylase in human blood serum.

57 ans and against deployment in and reuse from blood serum.

58 lent to 2%-20% of the ionic concentration in blood serum.

59 s and the major protein, HSA, present in the blood serum.

60 % vs 16% hydrolysis after 20 min), and human blood serum (30% vs 50% hydrolysis after 24 h).

61 A small amount of patient blood serum (5 muL) was taken for analysis and the repor

62 Blood serum, a common cell culture medium component, is

63 ope exchange was shown to be stable in human blood serum after incubation at 37 degrees C for at leas

64 ent in biliary fluid than in liver biopsy or blood serum after LT.

65 in both buffer and complex mixtures such as blood serum; after 15 rounds of selection with a structu

66 athological measures, including decreases in blood serum albumin infiltration.

67 negative hospitalised participants provided blood serum alongside saliva and sebum samples for analy

68 ong endothelial cell chemotactic activity of blood serum, an activity that is markedly diminished in

69 uses, we conducted extensive hematologic and blood serum analyses on infected ferrets to identify lym

70 CE-UV/MALDI MS method required only 2 muL of blood serum and allowed the performance of the total IgE

71 Detection methods of antibiotic residues in blood serum and animal derived foods are of great intere

72 n and quantitation of antibiotic residues in blood serum and animal foodstuffs are of great significa

73 GF at 1 nM directly in undiluted, unmodified blood serum and at 50 pM (1.25 ng/mL) in serum-diluted 2

74 ent circulating levels of metabolites in the blood serum and can be fitted over time for a wide range

75 Application to IL-6 detection using blood serum and cell culture medium demonstrates that FA

76 hocyte cell surface markers were measured in blood serum and cell fractions from asymptomatic infecte

77 measure antibodies against COVID-19 in human blood serum and dried blood spot samples.

78 ied for measuring adenosine concentration in blood serum and drug formulation samples.The herein desc

79 gnificantly the IL-17 and TNF-alpha level in blood serum and fluorescent imaging could enable us to d

80 ction and quantitation of chloramphenicol in blood serum and foodstuffs arse highly in demand.

81 ystems for analysis of real samples, such as blood serum and freshwater.

82 The accurate glucose determination in human blood serum and good recoveries achieved in spiked urine

83 tested by determination of glucose in human blood serum and nitrite in water based on addition/recov

84 irect detection of small molecule targets in blood serum and other complex matrices.

85 In this study, we employed blood serum and plasma samples collected from 29 subject

86 plex proteinaceous, real-world media such as blood serum and plasma, even diluted.

87 ntified essential and risk elements in horse blood serum and significant negative correlation between

88 in complex, multicomponent samples, such as blood serum and soil.

89 Spiked human blood serum and unknown real serum samples were analyzed

90 ), SO4(2-), and NO3(-)) which are present in blood serum and urine and found to be almost no interfer

91 Quantitative data obtained for Seronorm blood serum and urine reference materials were in excell

92 nvestigated by the detection of NGAL in both blood serum and urine samples.

93 the determination of UA, Tyr and AP in human blood serum and urine samples.

94 nt metals (Al, Co, Cr, Mn, Ni, Ti, and V) in blood serum and urine.

95 ccess to conventional diagnostic matrices of blood, serum and others.

96 its of quantification of TCC were 5 ng/mL in blood/serum and 10 ng/mL in urine, respectively.

97 ferritin reserves in both the liver and the blood serum, and also did not induce negative alteration

98 teroidal components and peptidic hormones in blood serum, and cognitive and physical tests were perfo

99 ssium ions in aqueous solutions, human whole blood serum, and human whole blood.

100 rates of reassociation, stabilities in human blood serum, and immunorecognition.

101 urine, blood serum, and in vitro model to show its direct clini

102 n validated using spiked samples (tap water, blood serum, and saliva) and bacteria media (blank broth

103 lities of the radiopeptides were assessed in blood serum, and their distribution coefficient was dete

104 depletion of the IgG from the sample, human blood serum, and thereby facilitate enrichment of the ot

105 ase mismatch from perfect target directly in blood serum, and under ideal conditions, observe statist

106 Vs isolated from A-549 cells, SH-SY5Y cells, blood serum, and urine from a lung cancer mouse model.

107 ation, multiple sample types including whole blood, serum, and food.

108 The 100% agreement between whole blood, serum, and plasma CRAG LFA results demonstrates t

109 The method was demonstrated with blood, serum, and plasma spotted on specimen collection

110 B, the sensitivities of the ICT-1 with whole blood, serum, and plasma were 83, 65, and 70%, respectiv

111 llus PCR Initiative for the testing of whole blood, serum, and plasma.

112 on models and is also highly up-regulated in blood, serum, and tissue infection models, indicating a

113 Whole blood, serum, and urine aliquots were prepared and are a

114 Aliquots of whole blood, serum, and urine from clinically characterized pa

115 ct analysis of illicit drugs in 4 muL of raw blood, serum, and whole urine.

116 hepatitis B virus, a nonenteric pathogen, is blood serum antibody titers against HBsAg.

117 We hypothesized that PCBs in human blood serum are consistent from year to year in people w

118 as casein, nonfat milk, egg yolk, and human blood serum, are used to explore its phosphopeptide enri

119 resents Raman hyperspectroscopic analysis of blood serum as an easy, fast, non-expensive, and minimal

120 r the isolation of FAP from cell lysates and blood serum as well as for its detection by ELISA, Weste

121 ential of the platinum electrode immersed in blood serum because the measured value reflects the stat

122 salts and human blood samples (whole blood, blood serum, blood plasma, and formed elements) was real

123 -C Fort and Madopar, water, urine, and human blood serum) by the standard addition method.

124 he analysis of a reference material of human blood serum, by the spike and recovery trials with seawa

125 1.38 (1.32 to 1.44), respectively; for cord-blood serum C-peptide level above the 90th percentile, 1

126 ly diagnosed neonatal hypoglycemia, and cord-blood serum C-peptide level above the 90th percentile.

127 th increased birth weight and increased cord-blood serum C-peptide levels.

128 is of ascorbic acid and dopamine in aqueous, blood serum, cerebrospinal fluid, and pharmaceutical sam

129 trated here for N-glycans derived from human blood serum collected from a healthy individual and a br

130 Urine and blood serum, collected on the last day of exposure, were

131 multifunctional resin to remove interfering blood serum components, followed by (iii) detecting the

132 validation demonstrated that umbilical cord blood serum concentration of PGLYRP-1, a specific granul

133 Blood serum concentrations of CRP, maternal depression s

134 frequency; this concentration is typical of blood serum concentrations when the drug is utilized in

135 Also, they displayed higher levels of blood serum corticosterone, as well as decreased body we

136 The nanotube concentration in the blood serum decreased exponentially with a half-life of

137 titative measurements of N-linked glycans in blood serum, distinguishing breast cancer patients from

138 gue diagnosis in phosphate buffer saline and blood serum environments (up to the neat level).

139 wed markedly decreased survival in blood and blood serum ex vivo.

140 for 2 h, 10% ethanol for 1 day, or undiluted blood serum for 5 days.

141 ermine 8-proteins simultaneously in 5 muL of blood serum for prostate cancer diagnostics.

142 termine 8-proteins simultaneously in 5 uL of blood serum for prostate cancer diagnostics.

143 e area percentage of each fatty acid in cord blood serum from 12 infants born to control women (who c

144 ement with a glycomic investigation of whole blood serum from a much larger lung cancer cohort.

145 ple, a comparative study was conducted using blood serum from a small group of lung cancer patients a

146 We analyzed blood serum from children and their mothers from urban a

147 work provides a thermodynamic description of blood serum from patients diagnosed with Bence Jones mye

148 e found that rh proSP-C BRICHOS has a longer blood serum half-life compared with rh Bri2 BRICHOS and

149 ection of human IgA deficiency in real human blood serum has been developed.

150 disorders based on multiple cytokines in the blood serum has varied accuracy, and it is difficult to

151 valuated using model glycoproteins and human blood serum (HBS) spotted on glass or Teflon slides.

152 mponent, CD4(+) cell count, concentration of blood serum HIV-1 RNA, and the presence of breast inflam

153 nderwent prostate biopsy and measurements of blood serum IGF-I, IGF-II, IGFBP-2, and IGFBP-3 obtained

154 x overlapping signals in (1)H NMR spectra of blood serum in a long-term study of caloric restriction

155 lective determination of tryptophan (TRP) in blood serum in the presence of tyrosine.

156 d metabolites, two biomolecules available in blood serum, in order to comprehend the immediate impact

157 strategy to sense target molecules in human blood serum is achieved by immobilizing aptamers (APTs)

158 Blood serum is commonly used for clinical diagnostics be

159 Bilirubin (BR) in blood serum is elevated during jaundice (a common compli

160 Monitoring of myoglobin (Mb) in human blood serum is highly in demand for early diagnosis of a

161 ibiotic residues in animal derived foods and blood serum is of great interest.

162 Acid phosphatase activity in the blood serum is usually separated into tartrate-resistant

163 ation of albumin, the predominant protein in blood serum, is known to be a sensor of pathologies in t

164 Compared to conventional analysis of blood serum, it offers the advantage of noninvasive coll

165 ricated using this DNA aptamer are stable in blood serum, its lower affinity pushes their detection l

166 no metabolites were detected in mouse urine, blood serum, kidney, and liver homogenates 30 min after

167 deal of interest in the correlation between blood serum levels and the severity of risk for cardiova

168 ation and meta-analyses for variation in the blood serum levels of 129 metabolites as measured by the

169 We investigated temporal trends of blood serum levels of 13 perfluorinated alkyl acids (PFA

170 Here we measured blood serum levels of 5 dementia-related biomarkers (Abe

171 Overall, females had higher blood serum levels of corticosterone.

172 ubsequently found significant differences in blood serum levels of glycine (P = 4.04 x 10(-6)) and se

173 IL-36gamma peripheral blood serum levels were found to be closely associated w

174 Doses were titrated to achieve initial drug blood serum levels within the therapeutic range in child

175 capture could be achieved in the presence of blood serum, making the assay amenable to the analysis o

176 can detect tobramycin in filtered undiluted blood serum, measuring concentrations down to 10 muM wit

177 esonance spectroscopy was used to profile 32 blood serum metabolites obtained (before and after contr

178 l was to determine the extent and pattern of blood serum monitoring of mood stabilizers in Medicaid p

179 f human serum glycoproteins, i.e., the human blood serum N-glycome, is both complex and constrained b

180 rial interaction with host tissues including blood serum, nasal secretions, and pulmonary surfactant.

181 Two hours after 2-NP administration, rat blood serum nitrate plus nitrite levels were approximate

182 The RP values were measured in blood serum of 63 apparently healthy subjects.

183 First, total IgE quantification in the blood serum of a milk allergic patient by the IACE-UV te

184 pplied to the spectral dataset acquired from blood serum of a mouse model of Duchenne muscular dystro

185 Additionally, blood serum of control patients (n = 10) was sequentiall

186 peptides that specifically increased in the blood serum of M. bovis-infected animals).

187 peptides that specifically increased in the blood serum of M. bovis-infected animals).

188 Monitoring of the RP in the blood serum of patients was performed as a noninvasive m

189 M activity in the lung tumor environment and blood serum of patients with non-small cell lung cancer

190 applicable to antibody purification from the blood serum of seven different mammalian species and for

191 agnetic resonance spectroscopy of peripheral blood serum of swine and patients undergoing angioplasty

192 isoforms of ASM were acutely secreted in the blood serum of wild-type mice after 15 Gy radiation dose

193 he diazaborine formation can be performed in blood serum or cell lysates with minimal interference fr

194 -free affinity biosensors for diagnostics in blood serum or plasma samples.

195 ethod, a sample of biological fluid, such as blood serum or urine, is filtered through a 10,000 molec

196 background binding to amorphous aggregates, blood serum, or cell lysate.

197 ultrasound when suspended in aqueous media, blood serum, or diluted blood.

198 rgeted protein from a complex sample such as blood, serum, or cell lysate.

199 c immunoassay results using a single drop of blood, serum, or plasma.

200 ay achieves the determination of cortisol in blood serum over the range of clinical interest (1-60 mi

201 of thiols at various concentrations in human blood serums, paving a new way to develop multiparameter

202 d with those of gadopentetate dimeglumine in blood serum phantoms at 1.5 T, 3 T, and 7 T.

203 Data suggest that POCTs of blood (serum, plasma, or whole blood) have the highest a

204 ion of nimesulide in real samples like human blood serum, plasma and urine samples as well as some ph

205 per handling and shipping were developed for blood, serum, plasma, FFPE, and fresh/frozen tissue.

206 lyzed and stratified by specimen type (whole blood, serum, plasma, or oral fluid) or test type (POCT

207 In particular, blood serum/plasma and diabetic urine samples contain hi

208 for routine NMR-based metabolomics of human blood serum/plasma and should be considered as an altern

209 Fortified human blood serum, protein digest and fractions collected afte

210 We explored cord blood serum proteins by profiling a UCB pool of 12 neona

211 analysis of changes in the heat capacity of blood serum proteins can provide an insight into patient

212 ntial scanning calorimetry (DSC) analysis of blood serum proteins could reveal the patient response t

213 Turnover of blood serum proteins is a vital function in mammals, but

214 revent SERS-hotspot blockages and fouling by blood-serum proteins.

215 advance current knowledge of the human cord blood serum proteome.

216 16 M. bovis proteins were discovered in the blood serum proteomics data sets.

217 zyme-based sensors will not function, and in blood serum: reflecting selectivity and robustness as a

218 , the measurement of redox potential (RP) in blood serum reflects the prooxidant-antioxidant balance

219 n detection in physiological buffers such as blood serum remains difficult due to Debye screening, no

220 Monitoring of blood serum RP was performed in 64 liver transplant pati

221 ays, was successfully evaluated using spiked blood serum sample obtaining excellent recovery values i

222 ructural isomers of N-glycans derived from a blood serum sample of a cancer patient were also analyze

223 cessfully evaluated by detection of DCF in a blood serum sample without interference from the sample

224 ly evaluated by the detection of OH-PCB in a blood serum sample.

225 ed by determination of epirubicin in a human blood serum sample.

226 ric flow system for glucose determination in blood serum samples after enzymatic reaction with glucos

227 ct extracellular DNA and proteins from human blood serum samples and deliver these to two separate ou

228 ped sensor was used to detect sialic acid in blood serum samples and the results were in good agreeme

229 -free methods for its assessment directly in blood serum samples are lacking.

230 Human blood serum samples from 30 University of Pittsburgh Med

231 he package is illustrated with a data set of blood serum samples from 7 diet induced obese (DIO) and

232 t the sensor was able to quantify cocaine in blood serum samples in the range of concentrations betwe

233 this reagent for quantification of ACY-1 in blood serum samples is also explored.

234 al and laboratory data as well as CSF and/or blood serum samples of 237 participants, including 98 pa

235 um of 9 uveal melanoma cell lines and in the blood serum samples of 24 mice with uveal melanoma xenog

236 was successfully applied to the analysis of blood serum samples of five different men and women with

237 employed for the estimation of uric acid in blood serum samples of healthy individuals.

238 medium of uveal melanoma cell lines and the blood serum samples of mice with uveal melanoma xenograf

239 lycomic profiling of N-glycans released from blood serum samples of patients with different esophagea

240 Peripheral blood serum samples of RA patients contained substantial

241 t in uveal melanoma cell cultures and in the blood serum samples of xenotransplanted mice, of healthy

242 2D-IR spectra of blood serum samples supplemented with varying concentrat

243 he method was applied to (1)H NMR spectra of blood serum samples to demonstrate the selective identif

244 and reliable detection of free bilirubin in blood serum samples using human serum albumin (HSA) stab

245 In 24 patients, paired peripheral blood serum samples were available for analysis.

246 Blood serum samples were collected to monitor compliance

247 Before surgery, fresh urine and blood serum samples were obtained from human participant

248 clinical study was carried out on 23 patient blood serum samples with successful COVID-19 diagnosis,

249 concentration of serotonin in 70 muL of mice blood serum samples without additional pretreatment.

250 hment of glycoproteins from 1 muL volumes of blood serum samples, performed in triplicate for each le

251 249 confirmed NCC-positive and 401 negative blood serum samples, the sensitivity of the recombinant

252 measurement as well as efficient handling of blood serum samples.

253 ully used for detection of free bilirubin in blood serum samples.

254 Sensor was used to analyze glucose in blood serum samples.

255 NE in pharmaceutical formulations, urine and blood serum samples.

256 ethod was successfully tested by using human blood serum samples.

257 s was demonstrated in analyses of the spiked blood serum samples.

258 physiological levels of creatinine in human blood serum samples.

259 in the determination of MUC1 spiked to human blood serum samples.

260 ully applied for the determination of Cys in blood serum samples.

261 e real samples such as drug, milk, honey and blood serum samples.

262 ns from model glycoproteins and pooled human blood serum samples.

263 oeconomic status were evaluated using direct blood serum sampling and ADOS.

264 ins against a target antigen (antibodies) in blood/serum (serodiagnosis).

265 form well even when challenged directly with blood serum, soil and other complex, multicomponent samp

266 ction directly in complex matrices including blood serum, soil, and foodstuffs.

267 on range needed for the analysis of clinical blood serum specimens.

268 t proved to be metabolically stable in human blood serum (t(1/2) 7 vs 1.5 h for ADP).

269 In addition, 7A was stable in human blood serum, t1/2 of 15 vs 1.5 h for ADP, and resisted h

270 However, in the presence of blood serum, the lowest detection limit is 209 +/- 10 pp

271 is of commercial tablets, beverage and human blood serum.Therefore, the present electrode holds great

272 probe has also been tested on sample having blood serum to check the reliability of the sensor.

273 paring biosensors to detect glucose level in blood serum, urea level in urine solution, hemoglobin, i

274 mL(-1) for epinephrine (S/N = 3) in aqueous, blood serum, urine and pharmaceutical samples.

275 for the analysis of codeine and morphine in blood serum, urine samples and pharmaceutical formulatio

276 pplied for the determination of PSA in human blood serum, urine, and forensic samples without any cro

277 microheterogeneity of C9 purified from human blood serum, using an integrative workflow combining hig

278 Of those blood serum variables that gave highly significant negat

279 ection of anti-PEG abs directly from diluted blood serum was achieved within 40 min.

280 Blood serum was added with multiple amounts of CEs to ob

281 e major polyphenol of red wine (catechin) in blood serum was also measured at the end of the study.

282 metric biosensor for the detection of CRP in blood serum was developed herein based on controlled and

283 aires and folate levels in maternal and cord blood serum was examined in relation to infant allergic

284 Interestingly, testosterone in the blood serum was higher in the PE-fed group (11.01+/-1.48

285 Here, the blood serum was sampled from 104 AAAD+ patients and 103

286 Using blood serum, we found similar dysregulation of miR-124-3

287 and 7, the concentrations of azithromycin in blood serum were 0.22 +/- 0.02, 0.08 +/- 0.02, and 0.04

288 d the kynurenine:tryptophan ratio in patient blood serum were determined for stage III NSCLC patients

289 types of dirt and leaves, coal fly ash, and blood serum, were analyzed quantitatively for dissolved

290 selective sensors for a specific analyte in blood serum, which contains a large number of proteins,

291 etection of 1.2 pg mL(-1) (42 fM) PSA in 25% blood serum, which is about ten times more sensitive tha

292 tection limit of 10 nM was found using human blood serum, which is well below the diagnostic cutoff p

293 ical and label-free biosensor for insulin in blood serum with a clinically relevant linear range and

294 lowed detection and quantification of HSA in blood serum with a sensitivity limit of 3 nM.

295 ombines Raman hyperspectroscopic analysis of blood serum with advanced statistical analysis.

296 ncentrations but also of doing this in whole blood serum with interfaces that were, subsequently, reu

297 Free bilirubin could be detected in human blood serum with this potentiometric sensor.

298 sfully demonstrated by the analysis of human blood serums with a certified CRP and CCP content.

299 sed by detection of STR in a spiked milk and blood serum without interference from the sample matrix.

300 tection directly in complex samples (such as blood serum) without the need for target modification, p